Clinical Trials

NCT Number: NCT03861676 Phase: EARLY_PHASE1 Trial Summary: The Principal Investigator’s (PI) working hypothesis is that the PI can utilize the high predictive value of 18F-DCFPyl PSMA to identify clinically significant tumors in patients who will undergo brac- clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym:

NCT Number: NCT04709276 Phase: PHASE2 Trial Summary: The purpose of this study is to evaluate the safety and efficacy of a combination of nivolumab, ipilimumab, cabazitaxel and carboplatin in men with neuroendocrine prostate cancer (NEPC) or other aggre- clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym: CHAMP

NCT Number: NCT05700903 Phase: PHASE4 Trial Summary: This study plans to learn more about contributors to high blood pressure in men who undergo androgen deprivation therapy (ADT) to treat prostate cancer. Prostate cancer is the most common non-skin can- clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym: ARCH

NCT Number: NCT05877144 Phase: NA Trial Summary: This phase I clinical trial studies how well low intensity shockwave therapy (LiSWT) improves erectile function in patients who have had nerve-sparing radical prostatectomy (NS-RP), a type of surgery – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym:

NCT Number: NCT05899361 Phase: NA Trial Summary: This research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and ultrasound probe imaging will aid in redu- clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym:

NCT Number: NCT06054867 Phase: NA Trial Summary: The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer. Participants will go through baseline and follow up assess- clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym:

NCT Number: NCT06056830 Phase: PHASE3 Trial Summary: The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.- clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym: CLARIFY

NCT Number: NCT06059118 Phase: PHASE2 Trial Summary: Asymptomatic patients with metastatic castrate resistant prostate cancer (mCRPC) without pain due to prostate cancer will be treated on an open label study to evaluate effectiveness of sequential trea- clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym:

NCT Number: NCT04706962 Phase: PHASE1 Trial Summary: Open label first-in-human study of TH1902 in solid cancer, with 4 sequential parts: Part 1 (dose escalation): patients with recurrent advanced solid tumors (all comers) that have relapsed or are refr – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Theratechnologies Acronym:

NCT Number: NCT04556045 Phase: NA Trial Summary: This study is being done to determine if patients receiving personalized exercise therapy (versus those who do not receive personalized exercise therapy) have improved quality of life and physical fun – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Case Comprehensive Cancer Center Acronym: